promising

Experimental psychedelic therapy of the British company Beckley Psytech has considerably reduced the symptoms of depression resistant to treatment in a mid-term test, according to recently published data, which increases the expectations of a class of drugs which are directed towards potential approval by American regulators. Companies like Beckley, Atai Life Sciences and Compass Pathways […]